Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de John Chongbo Rim
Age : 60
Country of residence : Unknown
Linked companies : Samsung Biologics Co.,Ltd.

Biography of John Chongbo Rim 
Presently, John Chongbo Rim is President, Chief Executive Officer & Director at SAMSUNG BIOLOGICS Co., Ltd.


Current positions of John Chongbo Rim 
John Chongbo Rim : Personal Network 
Most Read News 
01/18ELON MUSK : Tesla investors urge judge to order Musk repay $13 billion for SolarCity deal
RE
01/13JACK DORSEY : Jack Dorsey's Block to build an open bitcoin mining system
RE
01/14ELON MUSK : Musk says Tesla to accept dogecoin for merchandise
RE
01/27ELON MUSK : human-like robots and self-driving cars
RE
01/20ALAN JOPE : Unilever strategy under scrutiny after short-lived GSK skirmish
RE
01/27BERNARD ARNAULT : LVMH has pricing power to counter inflation, but must be reasonable-Arnault
RE
01/24ELON MUSK : Tesla countersues JPMorgan, claims bank sought 'windfall' after Musk tweet
RE
01/23NELSON PELTZ : Nelson Peltz's Trian builds stake in Unilever - source
RE
01/26WILLIAM ACKMAN : Ackman's Pershing Square takes new position in Netflix
RE
01/25JOHN HESS : Hess Corp sees higher capital spending, production in 2022
RE
More news


© 2022 People and Ownership :   
John Chongbo Rim : Connections 


Latest news about John Chongbo Rim 
2021Samsung Biologics, AstraZeneca expand tie-up to include COVID-19 and cancer therapy
RE
2021Samsung Biologics, AstraZeneca expand tie-up to include COVID-19 and cancer therapy
T3
2021Samsung Biologics Eyes Expansion in US, Europe
MT
2021SAMSUNG BIOLOGICSá : South Korea's Samsung Biologics to add mRNA vaccine production line
T3
2021SAMSUNG BIOLOGICS : South Korea's Samsung Biologics to add mRNA vaccine production line
RE
2021MARKET CHATTER : Samsung Biologics Shares Jump 2% over Vaccine Deal Hopes with Moderna
MT
2020Samsung Biologics Announces Executive Changes
CI
More news